Your personal AI helper in the battle against skin cancer.
Biomarkers detection
- Squamous Cell Carcinoma
- Melanoma
- Basal Cell Carcinoma
- Mitoses
- Emboli
Interested in Cleo Skin?
Improve your workflow with an AI solution that you can trust.
Cleo Skin is an all-in-one AI powered primary diagnostic solution. We collaborated with leading European laboratories for clinical use in automated detection and quantification of tumor biomarkers in skin tissue.
Cleo Skin is designed to detect presence or absence of dedicated biomarkers of skin tissue lesions, based on numerized image analysis of histological Whole Slide image (WSI or digitized slides of histological tissue samples).
Cleo Skin provides pathologists with an automatic reading of skin cancer diagnosis fully integrated with the laboratory machines.
Cleo Skin is intended to be used as an aid to diagnosis and its results must be reviewed by accredited doctors.
Features
Biomarkers detection
Lesions & Classification
Precise detection of lesions and classification of each case as melanoma, squamous cell carcinoma, basal cell carcinoma and others.
Dimensions
Automatically measures the dimensions of the lesions.
Margins
Automatically measures the margins of the lesions.
Mitoses
Detection of objects and mitotic hotspots in the melanoma region. The algorithm also ensures automatic counting.
Features
Slides Priorization
Cleo Skin automatically prioritizes the most critical cases thanks to a first-read analysis and gives you access to a smart work list.
Features
Automatic Measurements of Dimensions & Margins
Cleo Skin offers automatic measurements of the tumor dimensions and of all margins.
First-Read Tool
Vendors Agnostic & Interoperable
All-in-one Platform
Data Protection*
Cleo Skin does not collect any personal data. Our activities are rigorously supervised in accordance with the General Data Protection Regulation (GDPR). All data stay within your personal network.